Business Description
Pharmarise Holdings Corp
ISIN : JP3802320006
Total Employee Number:
2,410Compare
Compare
Traded in other countries / regions
2796.Japan IPO Date
2007-02-21Description
Pharmarise Holdings Corp is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on the prescriptions issued by medical institutions. It is also engaged in the storage and management of medical examination records of patients on behalf of the medical institution.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.4 | |||||
Equity-to-Asset | 0.21 | |||||
Debt-to-Equity | 2.22 | |||||
Debt-to-EBITDA | 5.86 | |||||
Interest Coverage | 3.44 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.45 | |||||
Beneish M-Score | -2.91 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.5 | |||||
3-Year EBITDA Growth Rate | -2.6 | |||||
3-Year EPS without NRI Growth Rate | -42.8 | |||||
3-Year FCF Growth Rate | 2.4 | |||||
3-Year Book Growth Rate | -6.6 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 55.1 | |||||
9-Day RSI | 51.94 | |||||
14-Day RSI | 47.64 | |||||
3-1 Month Momentum % | -4.21 | |||||
6-1 Month Momentum % | -4.21 | |||||
12-1 Month Momentum % | 1.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.94 | |||||
Quick Ratio | 0.74 | |||||
Cash Ratio | 0.43 | |||||
Days Inventory | 23.57 | |||||
Days Sales Outstanding | 4.54 | |||||
Days Payable | 39.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.83 | |||||
Dividend Payout Ratio | 1.99 | |||||
Forward Dividend Yield % | 2.83 | |||||
5-Year Yield-on-Cost % | 2.83 | |||||
3-Year Average Share Buyback Ratio | -6.9 | |||||
Shareholder Yield % | 7.51 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 13.61 | |||||
Operating Margin % | 1.41 | |||||
Net Margin % | 0.16 | |||||
EBITDA Margin % | 3.72 | |||||
FCF Margin % | 3.68 | |||||
OCF Margin % | 4.72 | |||||
ROE % | 1.67 | |||||
ROA % | 0.36 | |||||
ROIC % | 0.62 | |||||
3-Year ROIIC % | -3.51 | |||||
ROC (Joel Greenblatt) % | 13.33 | |||||
ROCE % | 5.15 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 50.99 | |||||
PE Ratio without NRI | 69.77 | |||||
Shiller PE Ratio | 47.75 | |||||
Price-to-Owner-Earnings | 2.14 | |||||
PS Ratio | 0.08 | |||||
PB Ratio | 0.82 | |||||
Price-to-Free-Cash-Flow | 2.15 | |||||
Price-to-Operating-Cash-Flow | 1.69 | |||||
EV-to-EBIT | 15.05 | |||||
EV-to-EBITDA | 5.72 | |||||
EV-to-Revenue | 0.21 | |||||
EV-to-FCF | 5.8 | |||||
Price-to-GF-Value | 0.81 | |||||
Price-to-Projected-FCF | 0.29 | |||||
Price-to-Median-PS-Value | 0.71 | |||||
Earnings Yield (Greenblatt) % | 6.65 | |||||
FCF Yield % | 45.27 | |||||
Forward Rate of Return (Yacktman) % | 19.21 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharmarise Holdings Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 69,512 | ||
| EPS (TTM) (円) | 9.63 | ||
| Beta | 0.0363 | ||
| 3-Year Sharpe Ratio | -0.82 | ||
| 3-Year Sortino Ratio | -0.92 | ||
| Volatility % | 8.8 | ||
| 14-Day RSI | 47.64 | ||
| 14-Day ATR (円) | 4.997883 | ||
| 20-Day SMA (円) | 488.2 | ||
| 12-1 Month Momentum % | 1.21 | ||
| 52-Week Range (円) | 471 - 558 | ||
| Shares Outstanding (Mil) | 11.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pharmarise Holdings Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pharmarise Holdings Corp Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| JPY 14.000000 Cash Dividend | 2026-05-28 | 534.00 (+0.75%) | ||
| JPY 14.000000 Cash Dividend | 2025-05-29 | 493.00 (+0.61%) | ||
| 100:1 Stock Split | 2013-11-27 | 750.00 (-1.19%) | ||
| 3:1 Stock Split | 2011-11-28 | 396.33 (+1.45%) | ||
| 3:1 Stock Split | 2009-11-26 | 244.44 (-2.22%) |
Show
Entries
Pharmarise Holdings Corp Frequently Asked Questions
What is Pharmarise Holdings Corp(TSE:2796)'s stock price today?
The current price of TSE:2796 is 円491.00. The 52 week high of TSE:2796 is 円558.00 and 52 week low is 円471.00.
When is next earnings date of Pharmarise Holdings Corp(TSE:2796)?
The next earnings date of Pharmarise Holdings Corp(TSE:2796) is .
Does Pharmarise Holdings Corp(TSE:2796) pay dividends? If so, how much?
The Dividend Yield %  of Pharmarise Holdings Corp(TSE:2796) is 2.83% (As of Today), Highest Dividend Payout Ratio of Pharmarise Holdings Corp(TSE:2796) was 1.99. The lowest was 0.24. And the median was 0.41. The  Forward Dividend Yield % of Pharmarise Holdings Corp(TSE:2796) is 2.83%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Pharmarise Holdings Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers